Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

US holds back on pharma IP in Asia-Pacific trade talks
Pharma Times, UK
Wednesday, April 3, 2013 - 11:36am
tags:
intellectual property, PhRMA
FDA OKs Medtronic's artificial lung system for patients undergoing heart surgery
Yahoo/AP
Wednesday, April 3, 2013 - 11:33am
tags:
FDA, medronic, devices, artificial lung, Affinity Fusion
Pharma DTC ad spending sinks 11.5%, a $2B slide from 2006 peak
Fierce Pharma
Wednesday, April 3, 2013 - 11:31am
tags:
DTC
ViroPharma: Generic Concerns Overblown, Pipeline Will Bring Revenue Diversity
Seeking Alpha
Wednesday, April 3, 2013 - 10:55am
tags:
ViroPharma, Dyax, Shire, Halozyme, generics
Repligen Promises To Be A Cash Flow Machine
Seeking Alpha
Wednesday, April 3, 2013 - 10:53am
tags:
Repligen
Elan completes sale of Tysabri stake to Biogen
Reuters
Wednesday, April 3, 2013 - 10:51am
tags:
Tysabri, Elan, Biogen Idec, MS, multiple sclerosis
Why Anacor Is Poised to Pull Back
Motley Fool
Wednesday, April 3, 2013 - 10:50am
tags:
Anacor
A Clouded Future For Big Pharma's Blockbuster Diabetes Drugs
Seeking Alpha
Wednesday, April 3, 2013 - 10:48am
tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Novo Nordisk, Merck, Incretin
Biosimilars Could Be An Unlikely Boost For Pfizer
Seeking Alpha
Wednesday, April 3, 2013 - 10:46am
tags:
biosimilars, Pfizer, trastuzumab, Apixaban, tofacitinib
Pfizer, Novartis, Abbott weigh bids for Brazil's Ache - sources
Reuters
Wednesday, April 3, 2013 - 9:48am
tags:
Pfizer, Novartis, Brazil, Abbott Labs, Ache Laboratorios Farmaceuticos, M&A
Does The World Want, Much Less Need, A New Erectile Dysfunction Drug?
Forbes
Wednesday, April 3, 2013 - 9:46am
tags:
Avanafil, erectile dysfunction, Vivus, Stendra
Zalicus: Renewing Partnership With Novartis Will Be Vital For 2013 Revenues
Seeking Alpha
Wednesday, April 3, 2013 - 9:41am
tags:
Novartis, Zalicus, Z160
Valeant sweetens bid for Obagi Medical
Reuters
Wednesday, April 3, 2013 - 8:46am
tags:
Obagi Medical Products, Valeant Pharmaceuticals, M&A, Merz
Drugmakers to Benefit From Obama's Brain Initiative
Bloomberg
Wednesday, April 3, 2013 - 8:45am
tags:
Obama, brain research, Pfizer, Roche, Eli Lilly
Pfizer to Pay Bind Up to $210 Million in Nanotechnology Deal
Bloomberg
Wednesday, April 3, 2013 - 8:40am
tags:
Nanotechnoogy, Pfizer, Bind Therapeutics
U.S. trade office reviewing India's Supreme Court drug ruling
Reuters
Wednesday, April 3, 2013 - 8:39am
tags:
Novartis, Glivec, patents, India
Isis Publishes Encouraging Data
Yahoo/Zacks
Wednesday, April 3, 2013 - 8:38am
tags:
Isis Pharmaceuticals, antisense
AstraZeneca's MedImmune unit acquires AlphaCore Pharma
Yahoo/Fly on the Wall
Wednesday, April 3, 2013 - 8:37am
tags:
AstraZeneca, M&A, MedImmune, AlphaCore Pharma
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tuesday, April 2, 2013 - 10:58am
tags:
Arena Pharmaceuticals, Zogenix, Delcath, Aveo Pharmaceutical, Vivus, Titan Pharmaceuticals, Bristol-Myers Squibb, Merck, Gilead, AbbVie, Amarin, Achillion, Sangamo BioSciences, Raptor Pharmaceuticals, Vertex Pharmaceuticals, NewLink Genetics, AstraZeneca, Rigel, Depomed, Biogen Idec, Sucampo, Dendreon, Valeant Pharmaceuticals, GSK, Aegerion
Zalicus Granted Key Formulation Patent for Z160
Yahoo
Tuesday, April 2, 2013 - 10:54am
tags:
Z160, Zalicus

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.